Innovent Announces Mazdutide Demonstrates 80.2% Reduction in Liver Fat Content in Exploratory Analysis of Phase 3 Weight Management GLORY-1 Study at ADA 2024
SAN FRANCISCO and SUZHOU, China, June 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, reports the results of liver fat content from the Phase 3 study of mazdutide in Chinese adults with overweight...
NABR Commends the IUCN’s Decision to Reassess the Status of Long-Tailed Macaques
A Science-Based Approach Will Determine if the Species is Truly 'Endangered' WASHINGTON, June 25, 2024 /PRNewswire/ -- The National Association for Biomedical Research (NABR) commends the Union for the Conservation of Nature (IUCN)'s decision to reassess the 'Endangered' designation of long-tailed macaque monkeys (macaca fascicularis). "NABR is pleased that the IUCN will...
Science and Technology Daily: China’s Fertile Grounds for Innovation
BEIJING, June 24, 2024 /PRNewswire/ -- On June 24, ten experts received the China International Science and Technology Cooperation Award at the National Science and Technology Award Conference in Beijing. Science and Technology Daily: China's Fertile Grounds for Innovation They stand as eminent experts who have collaborated closely with their...
Bota Bio’s Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established
Bota's end-to-end bio-foundry tackles the challenge of transitioning from lab-developed technology to industrial-scale production, and empowers the rapid and efficient translation of cutting-edge biotechnology into tangible commercial value. SAN FRANCISCO, HANGZHOU and XINCHANG, China, June 24, 2024 /PRNewswire/ -- Bota Bio, a global industrial biotechnology company specializing in sustainable biomanufacturing solutions, and...
TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024
TU7710, long-acting recombinant activated factor VII, demonstrated a 5 to 7 times longer half-life in a Phase 1 study than that of NovoSeven, a conventional hemophilia treatment for patients who develop inhibitors TiumBio presented interim Phase 1a clinical data of TU7710 and discussed potential partnership at the ISTH 2024 SEONGNAM,...
iRegene Receives IND approval from U.S. FDA to Start Clinical Trial for Parkinson’s Disease
WUHAN, China, June 24, 2024 /PRNewswire/ -- On June 20 (UTC-4), the U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's Disease. This marks a significant milestone as NouvNeu001 becomes the world's first chemically induced allogeneic cell therapy product to enter clinical stages for Parkinson's disease in the...
Wingderm® Shines at IMCAS Asia 2024 with the Innovative Aesthetic Solutions
BEIJING, June 24, 2024 /PRNewswire/ -- From June 21 to 23, IMCAS Asia was held in Bangkok, Thailand. Wingderm®, a provider of medical aesthetic devices, has garnered significant attention with its innovative aesthetic solutions. Wingderm® at IMCAS Asia 2024 Many visitors stopped by Wingderm®'s booth and stayed for valuable insights. Wingderm® members communicated and discussed with...
Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares
ROCKVILLE, Md. and SUZHOU, China, June 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK) announced that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of American depositary shares representing its ordinary shares. The number of...
Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association’s 84th Scientific Sessions
BEIJING and BRIDGEWATER, N.J., June 23, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced the results of the Phase 1b/2a clinical study of the Company's independently developed glucagon-like peptide-1 (GLP-1) receptor agonist, GZR18 Injection, in an obese/overweight population in China, along with the results of two...
Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa
SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences (Caris)' solid tumour molecular profiling services in the Middle East and Africa (MEA). Caris is the leading next-generation AI TechBio company and precision medicine pioneer. This expansion...
